LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 1334 | 2879 | 3970 | 0.7250 | 0.5858 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 3 | A17 | 72 | hr | 1334 | 3138 | 3970 | 0.7903 | 0.6841 |
BT-20 | Nilotinib | 0.12 | uM | LJP5 | 1 | N17 | 72 | hr | 1334 | 4177 | 3970 | 1.0519 | 1.0782 |
BT-20 | Nilotinib | 0.12 | uM | LJP5 | 2 | N17 | 72 | hr | 1334 | 4290 | 3970 | 1.0804 | 1.1210 |
BT-20 | Nilotinib | 0.12 | uM | LJP5 | 3 | N17 | 72 | hr | 1334 | 3881 | 3970 | 0.9774 | 0.9659 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 1 | H05 | 72 | hr | 1334 | 4161 | 3970 | 1.0479 | 1.0721 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 2 | H05 | 72 | hr | 1334 | 4165 | 3970 | 1.0489 | 1.0736 |
BT-20 | Nintedanib | 0.12 | uM | LJP6 | 3 | H05 | 72 | hr | 1334 | 3798 | 3970 | 0.9565 | 0.9344 |
BT-20 | NU7441 | 0.12 | uM | LJP5 | 1 | C11 | 72 | hr | 1334 | 3908 | 3970 | 0.9842 | 0.9761 |
BT-20 | NU7441 | 0.12 | uM | LJP5 | 2 | C11 | 72 | hr | 1334 | 4157 | 3970 | 1.0469 | 1.0706 |
BT-20 | NU7441 | 0.12 | uM | LJP5 | 3 | C11 | 72 | hr | 1334 | 4235 | 3970 | 1.0665 | 1.1002 |
BT-20 | Dactolisib | 0.12 | uM | LJP5 | 1 | M17 | 72 | hr | 1334 | 1842 | 3970 | 0.4639 | 0.1924 |
BT-20 | Dactolisib | 0.12 | uM | LJP5 | 2 | M17 | 72 | hr | 1334 | 1743 | 3970 | 0.4389 | 0.1549 |
BT-20 | Dactolisib | 0.12 | uM | LJP5 | 3 | M17 | 72 | hr | 1334 | 1561 | 3970 | 0.3931 | 0.0859 |
BT-20 | NVP-TAE684 | 0.12 | uM | LJP6 | 1 | K17 | 72 | hr | 1334 | 3193 | 3970 | 0.8041 | 0.7049 |
BT-20 | NVP-TAE684 | 0.12 | uM | LJP6 | 2 | K17 | 72 | hr | 1334 | 2998 | 3970 | 0.7550 | 0.6310 |
BT-20 | NVP-TAE684 | 0.12 | uM | LJP6 | 3 | K17 | 72 | hr | 1334 | 3091 | 3970 | 0.7784 | 0.6662 |
BT-20 | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 1334 | 2288 | 3970 | 0.5762 | 0.3616 |
BT-20 | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 1334 | 3199 | 3970 | 0.8056 | 0.7072 |
BT-20 | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 1334 | 3416 | 3970 | 0.8603 | 0.7895 |
BT-20 | PD0325901 | 0.12 | uM | LJP5 | 1 | C05 | 72 | hr | 1334 | 3846 | 3970 | 0.9685 | 0.9526 |
BT-20 | PD0325901 | 0.12 | uM | LJP5 | 2 | C05 | 72 | hr | 1334 | 3858 | 3970 | 0.9716 | 0.9572 |
BT-20 | PD0325901 | 0.12 | uM | LJP5 | 3 | C05 | 72 | hr | 1334 | 3834 | 3970 | 0.9655 | 0.9481 |
BT-20 | PD0325901 | 0.12 | uM | LJP6 | 1 | E05 | 72 | hr | 1334 | 2670 | 3970 | 0.6724 | 0.5065 |
BT-20 | PD0325901 | 0.12 | uM | LJP6 | 2 | E05 | 72 | hr | 1334 | 4036 | 3970 | 1.0164 | 1.0247 |